EURO-BLCS Study
Welcome to the home page for the euro-blcs study
biological, clinical and genetic factors for future risk of cardiovascular diseases
The euro-blcs study sets out to explore the evolution of cardiovascular morbidity, mortality and intermediate disease markers throughout the lifecourse in children, adolescents, young adults, middle-aged and elderly people as a means of identifying high risk groups and biological markers amenable to early intervention and prevention.
The relationship between fetal, maternal, lifecourse and genetic factors and cardiovascular disease risk will be studied using data from our unique cohort collection:
northern finland birth cohorts (NFBC), national health and development survey (NSHD), ALSPAC cohort, greek national perinatal survey, faroe islands cohort
Improved understanding of the aetiology of cardiovascular disease and identification of markers of disease risk will have great benefits for public health in terms of early diagnosis and development of disease prevention and therapeutic strategies.
|
euro-blcs is a multi-national epidemiological study, funded by the fifth european community framework programme covering research, technological development and demonstration activities, under quality of life and management of living resources http://www.cordis.lu/life/ |
|
For further information on euro-blcs, see background
The 3rd Conference for Longitudinal Epidemiological Studies in Europe (CELSE) (organised in association with euro-blcs), will take place 22-24 September 2004 in Bristol, UK. For further information please email celse-3@bristol.ac.uk or contact the conference secreatary Leala Watson at L.K.Watson@bristol.ac.uk.
The 2nd CELSE was held in Oulu, Finland in June 2002 . For details of this event see http://kelo.oulu.fi/CELSE/
euro-blcs prinicipal investigator and study co-ordinator:
Professor Marjo-Riitta Jarvelin
Department of Epidemiology and Biostatistics, Imperial College London
Department of Public Health and General Practice, University of Oulu
euro-blcs research co-ordinator:
Vanessa King
Department of Epidemiology and Biostatistics, Imperial College London
